¥2,784.50
2.28%
Tokyo, Sep 18, 03:30 pm JST.
ISIN
JP3982400008
Symbol
4527

Rohto Pharmaceutical Co Stock price

¥2,784.50
+14.00 0.51% 1M
+394.50 16.51% 6M
+156.50 5.96% YTD
+239.00 9.39% 1Y
-1,275.50 31.42% 3Y
+992.00 55.34% 5Y
+1,935.00 227.78% 10Y
+2,193.00 370.75% 20Y
Tokyo, Closing price Fri, Sep 18 2026
-65.00 2.28%
ISIN
JP3982400008
Symbol
4527

Is Rohto Pharmaceutical Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
¥646.4b
Enterprise Value
¥619.8b
Net debt
positive
Cash
¥84.8b
Shares outstanding
226.0m
Valuation (TTM | estimate)
P/E
19.3
P/S
1.8 | 1.7
EV/Sales
1.8 | 1.7
EV/FCF
-
P/B
2.1
Dividends
DPS
¥50.00
Yield 1Y | 5Y
1.8% | 1.4%
Growth 1Y | 5Y
8.7% | 22.7%
Payout 1Y | 3Y
31.7% | 26.2%
Increased
8 Years
Financials (TTM | estimate)
Revenue
¥353.4b | ¥374.0b
EBITDA
-
EBIT
¥42.7b
Net Income
¥33.1b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
9.7% | 8.8%
EBITDA
-
EBIT
9.8%
Net Income
-3.4%
Free Cash Flow
-
Margin
Gross
56.2%
EBITDA
-
EBIT
12.1%
Net
9.4%
Free Cash Flow
-
Financial Health
Equity Ratio
62.1%
Return on Equity
11.4%
ROCE
11.3%
ROIC
9.0%
Debt/Equity
0.2
More
EPS
¥144.6
FCF per Share
-
Short interest
-
Employees
9k
Rev per Employee
¥37.6m

Rohto Pharmaceutical Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Rohto Pharmaceutical Co forecast:

11x Buy
73%
4x Hold
27%

Analyst Opinions

15 Analysts have issued a Rohto Pharmaceutical Co forecast:

Buy
73%
Hold
27%

Financial data from Rohto Pharmaceutical Co

Jun '26
+/-
%
353,385 353,385
10% 10%
100%
- Direct Costs 154,949 154,949
10% 10%
44%
198,436 198,436
9% 9%
56%
- Selling and Administrative Expenses 155,353 155,353
9% 9%
44%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 42,654 42,654
10% 10%
12%
Net Profit 33,128 33,128
3% 3%
9%

In millions JPY.

Don't miss a Thing! We will send you all news about Rohto Pharmaceutical Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 9,144 full-time employees. The firm operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).

Head office Japan
CEO Mr. Yamada
Employees 9,144
Website www.rohto.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today